Genetics/genomics in chronic kidney disease - Towards personalized medicine?

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 417-422

  Luttropp, Karin ^a   Lindholm, Bengt ^a,c   Carrero, Juan Jesus ^a   Glorieux, Griet ^b   Schepers, Eva ^b   Vanholder, Raymond ^b   Schalling, Martin ^a   Stenvinkel, Peter ^a   Nordfors, Louise ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; GENETIC MARKER; GENETICS; GENOTYPE; HUMAN; KIDNEY DISEASE; PATHOLOGY; PERSONALIZED MEDICINE;

CARDIOVASCULAR DISEASES; GENETIC MARKERS; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; KIDNEY DISEASES;

EID: 69249121990     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00592.x     Document Type: Article

References (35)

1. Perco P, Pleban C, Kainz A, Lukas A, Mayer G, Mayer B, Oberbauer R : Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest 36 : 753 763, 2006
2. Schena FP, Cerullo G, Torres DD, Zaza G, Cox S, Bisceglia L, Scolari F, Frascá G, Ghiggeri GM, Amoroso A : Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contrib Nephrol 157 : 80 89, 2007
3. Doi K, Okamoto K, Tokunaga K, Fujita T, Noiri E : Genome study of kidney disease in the age of post genome-sequencing. Endocr Metab Immune Disord Drug Targets 8 : 173 183, 2008
4. Courtney AE, McNamee PT, Heggarty S, Middleton D, Maxwell AP : Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy. Nephrol Dial Transplant 23 : 608 611, 2008
5. Stenvinkel P, Ekstrom TJ : Epigenetics - a helpful tool to better understand processes in clinical nephrology? Nephrol Dial Transplant 23 : 1493 1496, 2008
6. Zoccali C, Testa A, Spoto B, Tripepi G, Mallamaci F : Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis 47 : 332 341, 2006
7. Kottgen A, Kao WH, Hwang SJ, Boerwinkle E, Yang Q, Levy D, Benjamin EJ, Larson MG, Astor BC, Coresh J, Fox CS : Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 9 : 49, 2008
8. Arar NH, Voruganti VS, Nath SD, Thameem F, Bauer R, Cole SA, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE : A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol Dial Transplant 23 : 3184 3191, 2008
9. Salzler HR, Griffiths R, Ruiz P, Chi L, Frey C, Marchuk DA, Rockman HA, Le TH : Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. Kidney Int 72 : 1226 1232, 2007
10. Sheehan S, Tsaih SW, King BL, Stanton C, Churchill GA, Paigen B, DiPetrillo K : Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice. Am J Physiol Renal Physiol 293 : F1649 F1656, 2007
11. Doi K, Noiri E, Maeda R, Nakao A, Kobayashi S, Tokunaga K, Fujita T : Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients. Hypertens Res 30 : 1193 1198, 2007
12. Zychma MJ, Gumprecht J, Grzeszczak W, Zukowska-Szczechowska E : Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients. Nephron 92 : 235 239, 2002
13. Ksiazek P, Bednarek-Skublewska A, Buraczynska M : The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 10 : BR47 BR51, 2004
14. de Souza CM, Braosi AP, Luczyszyn SM, Avila AR, de Brito RB Jr., Ignácio SA, Probst CM, Riella MC, Sotomaior VS, Mira MT, Pecoits-Filho R, Trevilatto PC : Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis. Blood Purif 25 : 411 419, 2007
15. Buraczynska M, Ksiazek P, Kubit P, Zaluska W : Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure. Cytokine 36 : 167 172, 2006
16. Padiyar A, Sedor JR : Genetic and genomic approaches to glomerulosclerosis. Curr Mol Med 5 : 497 507, 2005
17. Rao M, Jaber BL, Balakrishnan VS : Gene polymorphism association studies in dialysis: cardiovascular disease. Semin Dial 18 : 217 225, 2005
18. Gumprecht J, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E : Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. Kidney Int 58 : 513 519, 2000
19. Perez-Oller L, Torra R, Badenas C, Mila M, Darnell A : Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 34 : 273 278, 1999
20. Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J : Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 63 : 1899 1907, 2003
21. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L : Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67 : 2383 2392, 2005
22. Lehtinen AB, Burdon KP, Lewis JP, Langefeld CD, Ziegler JT, Rich SS, Register TC, Carr JJ, Freedman BI, Bowden DW : Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 92 : 345 352, 2007
23. Braunersreuther V, Mach F, Steffens S : The specific role of chemokines in atherosclerosis. Thromb Haemost 97 : 714 721, 2007
24. Muntinghe FLH, Verduijn M, Zuurman MW, Grootendorst DC, Carrero JJ, Qureshi AR, Luttropp K, Nordfors L, Lindholm B, Brandenburg V, Stenvinkel P, Boeschoten EW, Krediet RT, Navis G, Dekker FW : CC-chemokine receptor 5 deletion (CCR5d32) polymorphism protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol, in press
25. Maruyama Y, Nordfors L, Stenvinkel P, Heimburger O, Bárány P, Pecoits-Filho R, Axelsson J, Hoff CM, Holmes CJ, Schalling M, Lindholm B : Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease. Blood Purif 23 : 384 393, 2005
26. Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJ HEMO Study Group : Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65 : 1449 1460, 2004
27. Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF : Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Exp Clin Endocrinol Diabetes 115 : 38 41, 2007
28. Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J : IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 17 : 863 870, 2006
29. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ : Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25 : 212 219, 2004
30. Liu Y, Berthier-Schaad Y, Plantinga L, Fink NE, Tracy RP, Kao WH, Klag MJ, Smith MW, Coresh J : Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients. J Am Soc Nephrol 17 : 3158 3166, 2006 (Pubitemid 44707776)
31. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP : Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 : 681 689, 2001
32. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, Packard CJ, O'Reilly DS, Juhan-Vague I, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Kooistra T, Stephens JW, Hurel SJ, Livingstone S, Colhoun HM, Miller GJ, Bautista LE, Meade T, Sattar N, Humphries SE, Hingorani AD : Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35 : 922 931, 2006
33. Zhang L, Kao WH, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J : C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 49 : 118 126, 2007
34. Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, Köhler H : Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62 : 949 955, 2002
35. Zaza G, Pontrelli P, Pertosa G, Granata S, Rossini M, Porreca S, Staal FJ, Gesualdo L, Grandaliano G, Schena FP : Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrol Dial Transplant 23 : 1673 1681, 2008